1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Colorectal Cancer Diagnostics & Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Colorectal Cancer Diagnostics
1.2.3 Colorectal Cancer Therapeutics
1.3 Market by Application
1.3.1 Global Colorectal Cancer Diagnostics & Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Colorectal Cancer Diagnostics & Therapeutics Market Perspective (2017-2028)
2.2 Colorectal Cancer Diagnostics & Therapeutics Growth Trends by Region
2.2.1 Colorectal Cancer Diagnostics & Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Colorectal Cancer Diagnostics & Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Colorectal Cancer Diagnostics & Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Colorectal Cancer Diagnostics & Therapeutics Market Dynamics
2.3.1 Colorectal Cancer Diagnostics & Therapeutics Industry Trends
2.3.2 Colorectal Cancer Diagnostics & Therapeutics Market Drivers
2.3.3 Colorectal Cancer Diagnostics & Therapeutics Market Challenges
2.3.4 Colorectal Cancer Diagnostics & Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Colorectal Cancer Diagnostics & Therapeutics Players by Revenue
3.1.1 Global Top Colorectal Cancer Diagnostics & Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Colorectal Cancer Diagnostics & Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Colorectal Cancer Diagnostics & Therapeutics Revenue
3.4 Global Colorectal Cancer Diagnostics & Therapeutics Market Concentration Ratio
3.4.1 Global Colorectal Cancer Diagnostics & Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Colorectal Cancer Diagnostics & Therapeutics Revenue in 2021
3.5 Colorectal Cancer Diagnostics & Therapeutics Key Players Head office and Area Served
3.6 Key Players Colorectal Cancer Diagnostics & Therapeutics Product Solution and Service
3.7 Date of Enter into Colorectal Cancer Diagnostics & Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Colorectal Cancer Diagnostics & Therapeutics Breakdown Data by Type
4.1 Global Colorectal Cancer Diagnostics & Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Colorectal Cancer Diagnostics & Therapeutics Forecasted Market Size by Type (2023-2028)
5 Colorectal Cancer Diagnostics & Therapeutics Breakdown Data by Application
5.1 Global Colorectal Cancer Diagnostics & Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Colorectal Cancer Diagnostics & Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Colorectal Cancer Diagnostics & Therapeutics Market Size (2017-2028)
6.2 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type
6.2.1 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2017-2022)
6.2.2 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2023-2028)
6.2.3 North America Colorectal Cancer Diagnostics & Therapeutics Market Share by Type (2017-2028)
6.3 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application
6.3.1 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2017-2022)
6.3.2 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2023-2028)
6.3.3 North America Colorectal Cancer Diagnostics & Therapeutics Market Share by Application (2017-2028)
6.4 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country
6.4.1 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2017-2022)
6.4.2 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size (2017-2028)
7.2 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Type
7.2.1 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2017-2022)
7.2.2 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2023-2028)
7.2.3 Europe Colorectal Cancer Diagnostics & Therapeutics Market Share by Type (2017-2028)
7.3 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Application
7.3.1 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2017-2022)
7.3.2 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2023-2028)
7.3.3 Europe Colorectal Cancer Diagnostics & Therapeutics Market Share by Application (2017-2028)
7.4 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Country
7.4.1 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2017-2022)
7.4.2 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Type
8.2.1 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Share by Type (2017-2028)
8.3 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Application
8.3.1 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Share by Application (2017-2028)
8.4 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Region
8.4.1 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size (2017-2028)
9.2 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type
9.2.1 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2017-2022)
9.2.2 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2023-2028)
9.2.3 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Share by Type (2017-2028)
9.3 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application
9.3.1 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2017-2022)
9.3.2 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2023-2028)
9.3.3 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Share by Application (2017-2028)
9.4 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country
9.4.1 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2017-2022)
9.4.2 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Type
10.2.1 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Share by Type (2017-2028)
10.3 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Application
10.3.1 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Share by Application (2017-2028)
10.4 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Country
10.4.1 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Biocept
11.1.1 Biocept Company Details
11.1.2 Biocept Business Overview
11.1.3 Biocept Colorectal Cancer Diagnostics & Therapeutics Introduction
11.1.4 Biocept Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
11.1.5 Biocept Recent Developments
11.2 Cancer Genetics
11.2.1 Cancer Genetics Company Details
11.2.2 Cancer Genetics Business Overview
11.2.3 Cancer Genetics Colorectal Cancer Diagnostics & Therapeutics Introduction
11.2.4 Cancer Genetics Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
11.2.5 Cancer Genetics Recent Developments
11.3 Foundation Medicine
11.3.1 Foundation Medicine Company Details
11.3.2 Foundation Medicine Business Overview
11.3.3 Foundation Medicine Colorectal Cancer Diagnostics & Therapeutics Introduction
11.3.4 Foundation Medicine Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
11.3.5 Foundation Medicine Recent Developments
11.4 Sysmex Corporation
11.4.1 Sysmex Corporation Company Details
11.4.2 Sysmex Corporation Business Overview
11.4.3 Sysmex Corporation Colorectal Cancer Diagnostics & Therapeutics Introduction
11.4.4 Sysmex Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
11.4.5 Sysmex Corporation Recent Developments
11.5 Danaher Corporation
11.5.1 Danaher Corporation Company Details
11.5.2 Danaher Corporation Business Overview
11.5.3 Danaher Corporation Colorectal Cancer Diagnostics & Therapeutics Introduction
11.5.4 Danaher Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
11.5.5 Danaher Corporation Recent Developments
11.6 Epigenomics
11.6.1 Epigenomics Company Details
11.6.2 Epigenomics Business Overview
11.6.3 Epigenomics Colorectal Cancer Diagnostics & Therapeutics Introduction
11.6.4 Epigenomics Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
11.6.5 Epigenomics Recent Developments
11.7 Illumina
11.7.1 Illumina Company Details
11.7.2 Illumina Business Overview
11.7.3 Illumina Colorectal Cancer Diagnostics & Therapeutics Introduction
11.7.4 Illumina Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
11.7.5 Illumina Recent Developments
11.8 Rosetta Genomics
11.8.1 Rosetta Genomics Company Details
11.8.2 Rosetta Genomics Business Overview
11.8.3 Rosetta Genomics Colorectal Cancer Diagnostics & Therapeutics Introduction
11.8.4 Rosetta Genomics Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
11.8.5 Rosetta Genomics Recent Developments
11.9 Exact Science Corporation
11.9.1 Exact Science Corporation Company Details
11.9.2 Exact Science Corporation Business Overview
11.9.3 Exact Science Corporation Colorectal Cancer Diagnostics & Therapeutics Introduction
11.9.4 Exact Science Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
11.9.5 Exact Science Corporation Recent Developments
11.10 Pathway Genomics Corporation
11.10.1 Pathway Genomics Corporation Company Details
11.10.2 Pathway Genomics Corporation Business Overview
11.10.3 Pathway Genomics Corporation Colorectal Cancer Diagnostics & Therapeutics Introduction
11.10.4 Pathway Genomics Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
11.10.5 Pathway Genomics Corporation Recent Developments
11.11 Taiho Pharma
11.11.1 Taiho Pharma Company Details
11.11.2 Taiho Pharma Business Overview
11.11.3 Taiho Pharma Colorectal Cancer Diagnostics & Therapeutics Introduction
11.11.4 Taiho Pharma Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
11.11.5 Taiho Pharma Recent Developments
11.12 Merck KGaA
11.12.1 Merck KGaA Company Details
11.12.2 Merck KGaA Business Overview
11.12.3 Merck KGaA Colorectal Cancer Diagnostics & Therapeutics Introduction
11.12.4 Merck KGaA Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
11.12.5 Merck KGaA Recent Developments
11.13 Amgen
11.13.1 Amgen Company Details
11.13.2 Amgen Business Overview
11.13.3 Amgen Colorectal Cancer Diagnostics & Therapeutics Introduction
11.13.4 Amgen Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
11.13.5 Amgen Recent Developments
11.14 Takeda
11.14.1 Takeda Company Details
11.14.2 Takeda Business Overview
11.14.3 Takeda Colorectal Cancer Diagnostics & Therapeutics Introduction
11.14.4 Takeda Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
11.14.5 Takeda Recent Developments
11.15 Roche
11.15.1 Roche Company Details
11.15.2 Roche Business Overview
11.15.3 Roche Colorectal Cancer Diagnostics & Therapeutics Introduction
11.15.4 Roche Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
11.15.5 Roche Recent Developments
11.16 Eli Lilly
11.16.1 Eli Lilly Company Details
11.16.2 Eli Lilly Business Overview
11.16.3 Eli Lilly Colorectal Cancer Diagnostics & Therapeutics Introduction
11.16.4 Eli Lilly Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
11.16.5 Eli Lilly Recent Developments
11.17 Sanofi
11.17.1 Sanofi Company Details
11.17.2 Sanofi Business Overview
11.17.3 Sanofi Colorectal Cancer Diagnostics & Therapeutics Introduction
11.17.4 Sanofi Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
11.17.5 Sanofi Recent Developments
11.18 Regeneron
11.18.1 Regeneron Company Details
11.18.2 Regeneron Business Overview
11.18.3 Regeneron Colorectal Cancer Diagnostics & Therapeutics Introduction
11.18.4 Regeneron Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
11.18.5 Regeneron Recent Developments
11.19 Bayer
11.19.1 Bayer Company Details
11.19.2 Bayer Business Overview
11.19.3 Bayer Colorectal Cancer Diagnostics & Therapeutics Introduction
11.19.4 Bayer Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
11.19.5 Bayer Recent Developments
11.20 Onyx
11.20.1 Onyx Company Details
11.20.2 Onyx Business Overview
11.20.3 Onyx Colorectal Cancer Diagnostics & Therapeutics Introduction
11.20.4 Onyx Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2017-2022)
11.20.5 Onyx Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
